<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01521195</url>
  </required_header>
  <id_info>
    <org_study_id>1000017147</org_study_id>
    <nct_id>NCT01521195</nct_id>
  </id_info>
  <brief_title>Oxygen Consumption In Critically Ill Children</brief_title>
  <official_title>A Pilot Study of the Relationship Between Oxygen Delivery and Consumption During Extracorporeal Membrane Oxygenation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to examine the relationship between DO2 and VO2 in critically ill&#xD;
      patients requiring an Extracorporeal Membrane Oxygenation (ECMO) machine. This machine can&#xD;
      provide complete support of heart and lung function. In so doing, the investigators will be&#xD;
      able to avoid physiologic coupling by increasing DO2 mechanically, by increasing blood flow&#xD;
      through the ECMO circuit.&#xD;
&#xD;
      Null Hypothesis:&#xD;
&#xD;
      Increased oxygen delivery, by means of an increased rate of extracorporeal blood flow, is not&#xD;
      associated with an increase in oxygen consumption.&#xD;
&#xD;
      Alternate Hypothesis:&#xD;
&#xD;
      Increased oxygen delivery, by means of an increased rate of extracorporeal blood flow, is&#xD;
      associated with an increase in oxygen consumption.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygen consumption (VO2)</measure>
    <time_frame>Baseline</time_frame>
    <description>VO2 will be measured using a mass spectrometer as this is the gold standard.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxygen consumption (VO2)</measure>
    <time_frame>30min</time_frame>
    <description>VO2 will be measured using a mass spectrometer as this is the gold standard.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxygen consumption (VO2)</measure>
    <time_frame>60min</time_frame>
    <description>VO2 will be measured using a mass spectrometer as this is the gold standard.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxygen consumption (VO2)</measure>
    <time_frame>90min</time_frame>
    <description>VO2 will be measured using a mass spectrometer as this is the gold standard.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial serum lactate level</measure>
    <time_frame>Baseline, 30min, 60min, 90min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen extraction ratio.</measure>
    <time_frame>Baseline, 30min, 60min, 90min</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Extracorporeal Membrane Oxygenation</condition>
  <arm_group>
    <arm_group_label>Patients on veno-arterial (VA) ECMO</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extracorporeal blood flow via ECMO machine</intervention_name>
    <description>Extracorporeal Membrane Oxygenation (ECMO) machine can provide complete support of heart and lung function.&#xD;
Extracorporeal blood flow will be given at baseline rate, increased by 25% and decreased by 25%</description>
    <arm_group_label>Patients on veno-arterial (VA) ECMO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients in the Critical Care Unit on veno-arterial ECMO.&#xD;
&#xD;
          -  Hemodynamic stability established, as adjudged by the treating CCU staff physician.&#xD;
&#xD;
          -  Informed consent by parent or legal guardian.&#xD;
&#xD;
          -  Approval by treating CCU staff physician to approach parents/guardians for consent&#xD;
             process at any given time.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients in the Critical Care Unit on veno-venous (VV) ECMO.&#xD;
&#xD;
          -  Inability to tolerate study period without red cell transfusion.&#xD;
&#xD;
          -  Presence of a large leak around the endotracheal tube (&gt; 10% tidal volume).&#xD;
&#xD;
          -  Patients requiring &gt; 70 % FiO2 at the time of potential enrollment.&#xD;
&#xD;
          -  Parent or legal guardian refuse consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Kavanagh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5V1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Tosoni A, La Rotta G, Breatnach C, Anand V, Foreman C, Davidson L, Redington AN, Kavanagh BP. Oxygen Delivery and Consumption Are Independent: Evidence from Venoarterial Extracorporeal Membrane Oxygenation in Resuscitated Children. Am J Respir Crit Care Med. 2015 Sep 15;192(6):765-7. doi: 10.1164/rccm.201502-0267LE.</citation>
    <PMID>26371816</PMID>
  </results_reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 18, 2012</study_first_submitted>
  <study_first_submitted_qc>January 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2012</study_first_posted>
  <last_update_submitted>July 22, 2021</last_update_submitted>
  <last_update_submitted_qc>July 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pediatric</keyword>
  <keyword>ECMO</keyword>
  <keyword>extracorporeal blood flow</keyword>
  <keyword>VO2</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

